ErgomedCompany research
Click on headlines below to download research
US is now the biggest market in the mix
Ergomed | 04/10/2021
Ergomed has released its full H121 results. H121 revenue numbers were included in the trading update in July 2021, while the full accounts released last…
Momentum continues with EBITDA upgrades
Ergomed | 11/08/2021
Ergomed’s H121 trading update highlights that operational momentum continues to be strong following its stellar performance in FY20. The order book…
FY21e EBITDA ‘materially ahead’ of consensus
Ergomed | 11/06/2021
Yesterday, Ergomed held its annual general meeting (AGM) and provided a high-level year to date trading update (four months to end-April 2021). The company…
What’s next after stellar 2020 performance?
Ergomed | 01/06/2021
Although most of 2020 was challenging for the contract research outsourcing (CRO) sector, for Ergomed it was a transformative growth period due to well-balanced…